Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Long-lived gadolinium based tumor targeted imaging and therapy agents

Long-lived gadolinium based tumor targeted imaging and therapy agents

US Patent 11623007 · Granted Apr 11, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phospholipid ether analogs for imaging and targeted treatment of pediatric solid2025
PSMA-targeting ligands with optimal properties for imaging and therapy2025
PSMA-targeting ligands with optimal properties for imaging and therapy2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Cationic cyclic amine and amphipathic transfection reagents2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunot2023
Sterilizable fiducial beacon strand for RF target tracking2023
Luminescent phospholipid analogs for the identification and isolation of circula2022
Luminescent phospholipid analogs for the identification and isolation of circula2022